4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-006985
EVP & Chief Technology Officer sold 12,296 shares at $10.05 ($123,521)
- EVP & Chief Technology Officer acquired 32,500 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HANLY ANN M. EVP & Chief Technology Officer | 2024-02-22 | Grant or award 10b5-1 | +32,500 | 147,076 | D | ||
| HANLY ANN M. EVP & Chief Technology Officer | 2024-02-22 | Sale 10b5-1 | −12,296 | $10.05 | $123,521 | 134,780 | D |
| Derivatives | |||||||
| HANLY ANN M. EVP & Chief Technology Officer | 2024-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +65,000 | 65,000 | D | ||
| Open-market sales · 12,296 sh · avg $10.05 · $123,521 | |||||||
Loading xslF345X05/wk-form4_1708994010.xml…